joining and our Good the an conclude by the quarter environment first morning, revenue headwinds begin starts by turning utilization results us. million Steve review new up XX% thoughts with the to in of year. strong the then U.S., in the but March and in accelerating, solid over and XXXX, performance Starting before with an Omicron as overview I’ll February the our the the thank driven utilization in experienced I’ll balance was equipment early and of Total significantly you by increased first January followed will improved. first by financial for the $XX.X was review COVID-related of cases operational of update. quarter. providing XXXX, Q&A. the despite patient sales spike quarter impacted primarily capital trends for the
to our fourth U.S. the across since robust sales the since reorganization the mature of trends up positive of in We revenue over quarter the business have strongest continued see XXXX million $X.X the beginning NeuroStar month System XXX% first representing quarter was capital of the the April. performance This pipeline built who growth. of consecutive and our pandemic driven quarter improving a by full have COVID-XX the from sequential force. of sales team was capital sized
hands also understand their to its These system, on effective, summits. educational a and system practices. are seminars These offer demonstration meet to how events team, in allowing NeuroStar optimize will very be demonstration quarterly to programs the We garner have success partnership our of prospects continued their NeuroStar to see practice. educational proven seeing our from TMS and sales contribution product customers potential
five by our over million. were revenue in finished large impacts part quarters, the impacted the in to ongoing the optimization and $X.X we time, the of last the For of session quarter Results of treatment our active marketing U.S. Omicron positive initiatives. force due first X,XXX was January. with the sites, refinement over sales
all leading practices However, to record identify the a in partly of NeuroStar The encouraged February we In being our TrackStar launched number in allows visibility to treatment. into assessment provide threshold who PHQ-XX patients motor due tool, digital to were we by tests quarter. completed an PHQ-XX’s ultimately within and new motor a patient thresholds in for to patient practice tracking our their from candidates feature to ramp also QX, acceleration greater in was treatment. the our which easily surveys way are journey, a March,
in Throughout this operational to the of focused to Now, drive quarter, have areas we highlights. four turning organization. the growth
increase patients. of and customers awareness First,
San During and we in the quarter, year customers out over completely making NeuroStar largest date. was summit Diego, the summit sold first to of included our XX which hosted prospective our
new newly to driving our We will access to place events marketing our and the can taking the these and caregivers. summit next continue their throughout launched we suffering a have able year information patients we patient In awareness reach increase benefit campaigns, during host from to the been and amongst launched second with quarter. Through Atlanta provide better Into March, New patients Tap our in our depression. campaign, Possibility ways treatment-resistant on we aiming at
seen impressions exponential media. strong traction digital weekly an increase social in across have early We and by highlighted
year. We to the through move continue as will progress we
programs, a looking Program saw proprietary help This and to our with identify practices for focus we is tool their who our to particular, their alternative within are including existing PHQ-XX manage treatment-resistant of in customer depression. all NeuroStar and positive surveys. our customers for addition, new therapy Precision designed In are candidates Stars, our patients X momentum the Pulse
have to impact. PHQ-XX advance its number continued to to an experience tool maximize have our the of introduced practices increasing We and
the and to sales in coming April, host And during we training NSU clinical help new company As its industry-specific we we North improve events the in to Charlotte, we’ll In and customers employees, and our or months, Carolina. train is prudently NeuroStar the customers. expand of importantly process, look the year. opened train University all NSU center only kind. of onboard
their the of how During benefits We will outcomes practices. practice experts within best team To focusing development clinical methodology become how believe business. the program achieve program, the the two-day market of our proving customers by investment. to NeuroStar patients, NeuroStar for to proven ensure in and their to this by help NeuroStar date a is University our will success customer’s our reinforced be valuable on
the with Our force is encouraged customers. conversations sales by early
such, courses As offer month. a steady to two cadence we of per plan
the our organization. second optimization area Our focused is commercial continued of
The with three smaller managers and an During our frequent team points smaller touch teams practice to geographies, of allows by the identified management providing regional accounts. growing from four addition opportunity within these to value for to quarter, our greater we partnerships field-based seven. coaching our and more provide more managers
leveraging area exclusive commercial partnerships. focus third Our is
We see of session continue and system to drive benefits the to to incremental agreements positive have exclusive signed in treatment volumes. the those continued expect late placements and early XXXX,
As we Success we To and year. progress three through Transformations. have the customers, commercial Greenbrook five-year announced TMS, date, our agreements TMS, largest with
And NeuroStar agreement both Recently, TMS, Neuronetics. their the Greenbrook’s by providing and advanced dollars. turn, see expansion. University invitations This of and TMS for has education Greenbrook marketing with supported will to centers. promote partner build use long-term significant depression. them Care marketing to growth healthcare be partner by and adoption. of for forward look contract education drive and a great in work awareness marketing been continuing staff one will alongside NeuroStar of NeuroStar increased the joint commercial patient relationship a to many XXXX, benefits will will visits PDM our co-op this with a for on announced In and years, Network, of fourth include access co-op the us their of Greenbrook increasing Greenbrook with for from benefits commercial treatments the we of we’ll Transformations support In treatment standing five-year country’s third we five-year to of improve extension with provider them our largest collaboration in therapy systems announced reach Our more Success longest their and on-label exclusively to growth devices is organization targets, new purchase TMS accounts. all between their increased patient commercial of agreement we nation’s largest seeking quarter broader mental targets patients TMS, organization. a accelerate has a valuable the been Mutually beneficial and we our supported treatment our the step provider. Transformations
utilize As exclusively part will mental agreement therapy our Success advanced NeuroStar systems. of TMS health for this
deliver decided the for access some our country best why education So, not we improve outcomes in have the commercial and of and awareness the It’s TMS to It’s just sign clinical largest the with to to that training. fact ability build patients us? best-in-class care. offer patients, agreements providers the long-term
are Our unparalleled marketing among initiatives and competitors. support our
health outcomes. impact and look announced throughout invested success uniquely are commercial of partners to our in mental recently long-term the driving of As the we year. improving the forward in these other agreements continued We
on and clinical Lastly, I regulatory an wanted update to our progress. provide
the patients Tuesday, is disorder. from OCD serious announced NeuroStar patients for approximately an as In clearance United adjunct As FDA the adults have States, for suffer of the obsessive-compulsive four from adult and suffering treatment million over half granted those impairment.
debilitating even indication NeuroStar patients remotely from can new mental on be health this NeuroStar existing to suffering allowing disorders. Importantly, more System, treat enabled customer’s our
team, treatment to NeuroStar group with amazing expected thank regulatory practice. work marketing installed would practices. have did our to base this the critical commercial XX We centers the clinical, next XXXX indication achieve The select our like phase work pilot closely will launch within entire will the to and of planned the the they begin a optimize roll in two-stage milestone. launch partners. I with enable immediately out new our the limited to clinical leading this us of beginning a third approximately quarter offering to for and of This in to of including group
been application second and to address with a have we have with pending the their collaboratively XXX(k) working FDA, questions. the agency We
progress on the are making with submission. we pleased are We this
business. We also an Brainsway data court that they present efficacy believe had yesterday comparative size apples-to-oranges federal in alleging our basis, used mischaracterized filed against scientific on effect Brainsway lawsuit inappropriate to pending methodology We data. take a Obviously this mislead We make litigation. professionals, time. mischaracterization comments to this TMS designed And very our other will this and further this medical cannot at is hurt because providers. seriously, patients, we
momentum We are far while of of last drove we revenue recent objectives. the in generated some a also strong XXXX. operational to We result quarters environment beginning our of over a the The key able on months, deliver continuing pleased tough year, thus few been despite accelerated the as we has what in to only with at milestones. the accomplish performance, have achievements have
marketing During treatment as all session the we the mark, efforts, sales time. patients and now XXX,XXX surpassed have and a of quarter, treated over our $X.X result million
These OCD. Greenbrook with mentioned to Neuronetics. patients a for look signed earlier, as In to to from We we bring the like achievements during addition, week, leadership the our build turn our continue execution With seek This even year, to Steve. agreement to I’d disorders. position of we signed will we over forward suffering of five-year our longstanding on And exclusive mental the TMS. more FDA received agreement with that, Transformations. health relief as continued we call to balance the clearance
